Site Search
293 Results (showing 1 - 25)
May 30, 2003
Celera Diagnostics next month will complete four of approximately six disease-association studies whose results, if validated, will become part of a suite of new multi-analyte-based diagnostic products, a Celera spokesman said last week...Subscribers: click headline for more
May 30, 2003
Asper Biotech and SNP-bioinformatics company BioData have co-developed and launched a tool for handling SNP-genotyping data.
May 30, 2003
First Genetic Trust and Howard University College of Medicine announced this week a partnership to develop a biobank of genetic and biological information from individuals of African descent, the Genomic Research in the African Diaspora Biobank.
May 30, 2003
Paul Kelly has been appointed CEO of Orchid Biosciences, filling a position that has been left vacant since Dale Pfost resigned as CEO in December 2002.
May 30, 2003
Protein crystallographers Eleanor Dodson and Venki Ramakrishnan were elected as fellows of the Royal Society last month.
May 30, 2003
Physicians or medical school students concerned that they will be ill-equipped to take advantage of pharmacogenomics may soon get one step closer to enlightenment...Subscribers: click headline for more
May 30, 2003
A gene found in sperm cells originally believed to play a role in immunosuppression and cardiovascular disease may instead affect male fertility, according to a study conducted by an international team of researchers.
May 30, 2003
US Senate Committee Approves Genetic Anti-Discrimination Bill
May 29, 2003
SNPTECH REPORTER SUBSCRIBERS: Celera Dx to Complete Four Studies for New ASRs in June; ViroSeq to Go UHTP
Celera Diagnostics next month will complete four of approximately six disease-association studies whose results, if validated, will become part of a suite of new multi-analyte-based diagnostic products. Subscribe. (https://www.snptech.com/subscribe.htmtarget=_blank)
May 28, 2003
Ming Tsuang will join the University of California, San Diego School of Medicine as a “university professor” and will direct the proposed UCSD Institute of Human Behavioral Genomics of the Department of Psychiatry.
May 28, 2003
AT A GLANCE Bruce Huebner, president, chief operating officer, Nanaogen. Previously -- executive vice president and chief operating officer, Gen-Probe.
May 28, 2003
BIOARRAY NEWS SUBSCRIBERS: New FDA Draft Guidance for IVD is First for Industry in More Ways Than One
So, just what exactly is the FDA thinking about the development and marketing of multiplexed microarray-based diagnostic products? Subscribe. (https://www.bioarraynews.com/subscribe.htm)
May 28, 2003
Lynx Therapeutics announced last week that its securities would trade on the Nasdaq SmallCap Market, the latest in a series of moves for the Hayward, Calif.-based microarray technology firm.